Industry
Pharma & biotech: email security compared
Pharma & biotech: 24 Swiss organisations in the email security index. Avg. score 65.5, 46 % with DMARC p=reject, 0 % without DMARC, 8 % with MTA-STS.
- 65.5/100Avg. score · Rank 3/30
- 46 %DMARC p=reject
- 29 %without effective DMARC
- 100 %DKIM
- 8 %MTA-STS
- 92 %Mailboxes at US providers
- p=reject1145.8 %
- p=quarantine625 %
- p=none729.2 %
- missing00 %
- Grade A28.3 %
- Grade B1041.7 %
- Grade C1250 %
- Grade D00 %
- USA2291.7 %
- unclear28.3 %
- Microsoft 365 21
- Self-hosted / other 2
- Google Workspace 1
- Proofpoint 6
- Hornetsecurity 1
- Mimecast 1
24 organisations, avg. score 65.5
24 organisations
| Organisation | Industry | Canton | Score | DMARC | SPF | DKIM | MTA-STS | Mailbox | Gateway |
|---|---|---|---|---|---|---|---|---|---|
| Octapharmaoctapharma.com | Pharma & biotech | SZ | 87 A | p=reject | -all | ✓ | enforce | Self-hosted / other | Proofpoint |
| Rocheroche.com | Pharma & biotech | BS | 87 A | p=reject | -all | ✓ | enforce | Google Workspace | – |
| Debiopharmdebiopharm.com | Pharma & biotech | VD | 80 B | p=reject | -all | ✓ | – | Microsoft 365 | – |
| Siegfriedsiegfried.ch | Pharma & biotech | AG | 80 B | p=reject | -all | ✓ | – | Microsoft 365 | Proofpoint |
| Sinteticasintetica.com | Pharma & biotech | TI | 80 B | p=reject | -all | ✓ | – | Microsoft 365 | – |
| Cerbios-Pharmacerbios.ch | Pharma & biotech | TI | 74 B | p=quarantine | -all | ✓ | – | Microsoft 365 | – |
| Bachembachem.com | Pharma & biotech | BL | 70 B | p=reject | -all | ✓ | – | Microsoft 365 | – |
| Galdermagalderma.com | Pharma & biotech | ZG | 70 B | p=reject | -all | ✓ | – | Microsoft 365 | Proofpoint |
| Novartisnovartis.com | Pharma & biotech | BS | 70 B | p=reject | -all | ✓ | – | Microsoft 365 | Proofpoint |
| Sandozsandoz.com | Pharma & biotech | BS | 70 B | p=reject | -all | ✓ | – | Microsoft 365 | – |
| Ferringferring.com | Pharma & biotech | VD | 69 B | p=quarantine | -all | ✓ | – | Microsoft 365 | – |
| Lonzalonza.com | Pharma & biotech | BS | 68 B | p=reject | ~all | ✓ | – | Microsoft 365 | – |
| Acinoacino.swiss | Pharma & biotech | ZH | 64 C | p=quarantine | -all | ✓ | – | Microsoft 365 | – |
| Basilea Pharmaceuticabasilea.com | Pharma & biotech | BL | 64 C | p=quarantine | -all | ✓ | – | Microsoft 365 | – |
| Celoniccelonic.com | Pharma & biotech | BS | 64 C | p=quarantine | -all | ✓ | – | Microsoft 365 | Hornetsecurity |
| IBSAibsagroup.com | Pharma & biotech | TI | 64 C | p=quarantine | -all | ✓ | – | Microsoft 365 | – |
| OM Pharmaompharma.com | Pharma & biotech | GE | 55 C | p=reject | permerror | ✓ | – | Microsoft 365 | – |
| AC Immuneacimmune.com | Pharma & biotech | VD | 51 C | p=none | -all | ✓ | – | Microsoft 365 | – |
| ADC Therapeuticsadctherapeutics.com | Pharma & biotech | VD | 51 C | p=none | -all | ✓ | – | Microsoft 365 | Mimecast |
| CSL Viforviforpharma.com | Pharma & biotech | SG | 51 C | p=none | -all | ✓ | – | Microsoft 365 | Proofpoint |
| Helsinnhelsinn.com | Pharma & biotech | TI | 51 C | p=none | -all | ✓ | – | Microsoft 365 | – |
| Idorsiaidorsia.com | Pharma & biotech | BL | 51 C | p=none | -all | ✓ | – | Microsoft 365 | – |
| Molecular Partnersmolecularpartners.com | Pharma & biotech | ZH | 51 C | p=none | -all | ✓ | – | Microsoft 365 | – |
| CSL Behring Schweizcslbehring.com | Pharma & biotech | BE | 49 C | p=none | ~all | ✓ | – | Self-hosted / other | Proofpoint |
More: Industry
- Watches, luxury & consumer goods 66.9
- Consulting & audit 66.8
- Pharma & biotech 65.5
- Public enterprises 64.5
- Telecom, IT & media 63.6
- Commodity trading 63.3
- Machinery & electrical 62.2
- Financial services 61.8
- Staffing & facility services 60.9
- Energy 60.5
- Health insurers 60.5
- Building materials 60.3
- Retail 60.1
- Transport & logistics 59.9
- Medtech 59.8
- Insurance 58.6
- Construction & real estate 58.2
- Universities & research 57.9
- Food & beverages 57.4
- Tourism & hospitality 57.3
- Chemicals & materials 56.8
- Cantonal administrations 55.7
- Banking 54.8
- Healthcare 54.8
- Intercantonal bodies 54.8
- Municipalities 50.9
- Automotive retail 50.2
- Pension funds 45.1
- Federal administration 44.8
- Courts & justice 39.8